Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US8211938B2 · kind B2 · utility
8Cited by
3References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 2, 2010 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Nov 8, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.